Effectiveness of COVID-19 vaccination in immune-mediated inflammatory diseases

被引：0
|
作者：
Sparks, Jeffrey A. [1 ,2 ]
Singh, Namrata [3 ]
Wallace, Zachary S. [2 ,4 ,5 ]
机构：
[1] Brigham & Womens Hosp, Div Rheumatol Inflammat & Immun, Boston, MA 02115 USA
[2] Harvard Med Sch, Dept Med, Boston, MA 02115 USA
[3] Univ Washington, Div Rheumatol, Seattle, WA 98195 USA
[4] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA
[5] Massachusetts Gen Hosp, Mongan Inst, Dept Med, Clin Epidemiol Program, Boston, MA 02114 USA
来源：
LANCET RHEUMATOLOGY | 2022年 / 4卷 / 06期
关键词：
D O I：
10.1016/S2665-9913(22)00109-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E380 / E382
页数：3
相关论文
共 50 条
  • [31] Immune-mediated thrombotic thrombocytopenic purpura following COVID-19 vaccination
    Picod, Adrien
    Rebibou, Jean-Michel
    Dossier, Antoine
    Cador, Berengere
    Ribes, David
    Vasco-Moynet, Claire
    Stephan, Caroline
    Bellal, Mathieu
    Wynckel, Alain
    Poullin, Pascale
    Peju, Edwige
    Ricard, Laure
    Kahn, Jean-Emmanuel
    Bouzid, Raida
    Benhamou, Ygal
    Joly, Berangere
    Veyradier, Agnes
    Coppo, Paul
    [J]. BLOOD, 2022, 139 (16) : 2565 - +
  • [32] IMPACT OF THE COVID-19 PANDEMIC ON PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES TAKING A BIOLOGIC THERAPY
    Halioua, B.
    Zetlaoui, J.
    Astruc, A.
    Testa, D.
    Bombezin-Domino, A.
    Radoszycki, L.
    [J]. VALUE IN HEALTH, 2020, 23 : S622 - S622
  • [33] Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic
    Torres, Tiago
    Puig, Luis
    [J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2020, 21 (03) : 307 - 311
  • [34] COVID-19 outcomes in patients with a history of immune-mediated glomerular diseases
    Gauckler, Philipp
    Kesenheimer, Jana S.
    Geetha, Duvuru
    Odler, Balazs
    Eller, Kathrin
    Laboux, Timothee
    Alberici, Federico
    Zappa, Mattia
    Chebotareva, Natasha
    Moiseev, Sergey
    Bonilla, Marco
    Jhaveri, Kenar D.
    Oniszczuk, Julie
    Audard, Vincent
    Costa, Denise
    Mastroianni-Kirsztajn, Gianna
    Bruchfeld, Annette
    Muto, Masahiro
    Windpessl, Martin
    Mayer, Gert
    Kronbichler, Andreas
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [35] Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic
    Tiago Torres
    Luis Puig
    [J]. American Journal of Clinical Dermatology, 2020, 21 : 307 - 311
  • [36] Symptoms of COVID-19 in Patients with Immune Mediated Inflammatory Diseases
    Schlosser, T.
    Krasselt, M.
    Elsing, L.
    Hecker, M.
    Holler, B.
    Hoffmeister, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2023, 17 : 950 - 952
  • [37] Symptoms and Severity of COVID-19 in Patients with Immune-Mediated Inflammatory Diseases: Experience of a University Medical Center
    Schlosser, Tobias
    Krasselt, Marco
    Elsing, Louis
    Hecker, Martin
    Holler, Babett
    Hoffmeister, Albrecht
    [J]. AUTOIMMUNE DISEASES, 2024, 2024
  • [38] Venous Thromboembolism After COVID-19 Infection Among People With and Without Immune-Mediated Inflammatory Diseases
    Khan, Rabia
    Kuenzig, M. Ellen
    Tang, Furong
    Im, James H. B.
    Widdifield, Jessica
    Mccurdy, Jeffrey D.
    Kaplan, Gilaad G.
    Benchimol, Eric I.
    [J]. JAMA NETWORK OPEN, 2023, 6 (10) : E2337020
  • [39] COVID-19 and immune-mediated inflammatory diseases: Why don't our patients get worse?
    Martinez-Taboada, Victor M.
    Lopez-Hoyos, Marcos
    Crespo, Javier
    Hernandez, Jose L.
    [J]. AUTOIMMUNITY REVIEWS, 2020, 19 (12)
  • [40] Direct and Indirect Impact of COVID-19 for Patients with Immune-Mediated Inflammatory Diseases: A Retrospective Cohort Study
    Belleudi, Valeria
    Rosa, Alessandro C.
    Poggi, Francesca R.
    Armuzzi, Alessandro
    Nicastri, Emanuele
    Goletti, Delia
    Diamanti, Andrea Picchianti
    Davoli, Marina
    Agabiti, Nera
    Addis, Antonio
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (11)
12345